Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)Tobias Welte, Antoní Torres, Steven M. Opal et al.|Intensive Care Medicine|2018Cited by 136
Concept for a study design in patients with severe community-acquired pneumonia: A randomised controlled trial with a novel IGM-enriched immunoglobulin preparation – The CIGMA studyTobias Welte, Antoní Torres, R. Phillip Dellinger et al.|Respiratory Medicine|2015Cited by 36